Leaflet KIDTRAYZE concentrate for solution for infusion

Indicated for: various therapeutic indications

Route of administration: infusion

Substance: combinations (miscellaneous therapeutic preparation)

ATC: B05XA31 (Blood and blood forming organs | I.v. solution additives | Electrolyte solutions)

General data about KIDTRAYZE

Substance: combinations
Date of last drug list: 01-09-2023
Commercial code: W69712001
Pharmaceutical form: concentrate for solution for infusion
Quantity: 20
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: FRESENIUS KABI NORGE AS - NORVEGIA
Holder: FRESENIUS KABI ROMANIA S.R.L. - ROMANIA
Number: 15079/2023/01
Shelf life: 3 years-after packing for marketing;after the first opening-it is used immediately